ACT Cape Breton Conference

September 25-26, 2025

Sydney, Nova Scotia

The Accelerating Clinical Trials Consortium will be meeting September 25-26, 2025 in Sydney, Nova Scotia to explore international developments and collaboration opportunities in clinical trials.

 

Highlights from the agenda include:

  • Exploring alternative patient consent, and permission to contact models
  • Discussions around improving access to trials for people who have been
    historically excluded
  • Updates on ACT-supported high-impact, high-quality clinical trials
  • Planning the future of the Canadian clinical trials landscape

 

Registration for the conference is now closed. 

For more information contact us at: act.canada@phri.ca

The Accelerating Clinical Trials Consortium is generously supported through multi-year funding from the Canadian Institutes of Health Research’s Clinical Trials Fund, as part of Canada’s Biomanufacturing and Life Sciences Strategy to ensure that Canadians are well served by a national clinical trials network.